| Application number | Title of the application | Filing Date | Status |
|---|
| 07/809291 | EXPRESSION OF CLONED GENES IN THE LUNG BY AEROSOL-AND LIPOSOME-BASED DELIVERY | Dec 16, 1991 | Abandoned |
| 07/807446 | GENE THERAPY | Dec 12, 1991 | Abandoned |
| 07/802370 | COMPOSITIONS AND METHODS FOR REGULATING CELLULAR SIGNAL TRANSDUCING SYSTEM | Dec 3, 1991 | Abandoned |
Array
(
[id] => 3014522
[patent_doc_number] => 05288490
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-02-22
[patent_title] => 'Thrombus-targeted complexes of plasminogen activator and fibrin fragments'
[patent_app_type] => 1
[patent_app_number] => 7/799699
[patent_app_country] => US
[patent_app_date] => 1991-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12568
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/288/05288490.pdf
[firstpage_image] =>[orig_patent_app_number] => 799699
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/799699 | Thrombus-targeted complexes of plasminogen activator and fibrin fragments | Nov 24, 1991 | Issued |
Array
(
[id] => 2966156
[patent_doc_number] => 05202246
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-04-13
[patent_title] => 'Treatment of immobilized matrices for preparation of pharmaceutical and biological products with anti-microbial agents to remove pyrogen-producing organisms and pyrogens'
[patent_app_type] => 1
[patent_app_number] => 7/798255
[patent_app_country] => US
[patent_app_date] => 1991-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3665
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/202/05202246.pdf
[firstpage_image] =>[orig_patent_app_number] => 798255
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/798255 | Treatment of immobilized matrices for preparation of pharmaceutical and biological products with anti-microbial agents to remove pyrogen-producing organisms and pyrogens | Nov 17, 1991 | Issued |
| 07/785876 | METHODS AND PREPARATIONS FOR PREVENTING ADHESIONS TO ORGANS AND PARTS OF ORGANS | Nov 3, 1991 | Abandoned |
Array
(
[id] => 3048127
[patent_doc_number] => 05324628
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-06-28
[patent_title] => 'Use of chymotrypsin for the inactivation of prekallikrein activator'
[patent_app_type] => 1
[patent_app_number] => 7/775587
[patent_app_country] => US
[patent_app_date] => 1991-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1875
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/324/05324628.pdf
[firstpage_image] =>[orig_patent_app_number] => 775587
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/775587 | Use of chymotrypsin for the inactivation of prekallikrein activator | Oct 14, 1991 | Issued |
| 07/769623 | ADENOVIRUS-MEDIATED TRANSFER OF GENES TO THE LUNG | Oct 1, 1991 | Abandoned |
| 07/770204 | PRODUCTION OF CFTR IN THE MILK OF TRANSGENIC MICE | Oct 1, 1991 | Abandoned |
Array
(
[id] => 3033537
[patent_doc_number] => 05300433
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-04-05
[patent_title] => 'Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions'
[patent_app_type] => 1
[patent_app_number] => 7/765479
[patent_app_country] => US
[patent_app_date] => 1991-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8501
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/300/05300433.pdf
[firstpage_image] =>[orig_patent_app_number] => 765479
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/765479 | Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions | Sep 24, 1991 | Issued |
| 07/764365 | ISOLATED AND PURIFIED DNA SEQUENCE CODING ANTIGEN EXPRESSED BY TUMOR CELLS AND RECOGNIZED BY CYTOTOXIC T CELLS, AND USE THEREOF | Sep 22, 1991 | Abandoned |
| 07/748438 | IMPLANTABLE CELLS THAT ALLEVIATE CHRONIC PAIN IN HUMANS | Aug 21, 1991 | Abandoned |
Array
(
[id] => 3567796
[patent_doc_number] => 05538722
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-23
[patent_title] => 'Isolation, growth, differentiation and genetic engineering of human muscle cells'
[patent_app_type] => 1
[patent_app_number] => 7/748348
[patent_app_country] => US
[patent_app_date] => 1991-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9245
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/538/05538722.pdf
[firstpage_image] =>[orig_patent_app_number] => 748348
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/748348 | Isolation, growth, differentiation and genetic engineering of human muscle cells | Aug 21, 1991 | Issued |
| 07/743075 | COMBINATION THERAPY USING INTERLEUKIN-2 AND TUMOR NECROSIS FACTOR | Aug 8, 1991 | Abandoned |
| 07/737853 | TRANSGENIC PROTEIN PRODUCTION | Jul 30, 1991 | Abandoned |
Array
(
[id] => 3039755
[patent_doc_number] => 05376631
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-12-27
[patent_title] => 'Fibrin(ogen) derivatives, process for their preparation and their use'
[patent_app_type] => 1
[patent_app_number] => 7/787780
[patent_app_country] => US
[patent_app_date] => 1991-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4105
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/376/05376631.pdf
[firstpage_image] =>[orig_patent_app_number] => 787780
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/787780 | Fibrin(ogen) derivatives, process for their preparation and their use | Jul 17, 1991 | Issued |
| 07/732432 | PROCESS FOR THE PASTEURIZATION OF PLASMA OR CONCENTRATES OF BLOOD COAGULATION FACTORS, II, VII, IX AND X | Jul 17, 1991 | Abandoned |
| 07/720837 | SITE SPECIFIC IN-VIVO ACTIVATION OF THERAPEUTIC DRUGS | Jul 10, 1991 | Abandoned |
Array
(
[id] => 2801162
[patent_doc_number] => 05147641
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-09-15
[patent_title] => 'Microcapsule for the removal of specific amino acids through the entero-portal recirculation'
[patent_app_type] => 1
[patent_app_number] => 7/719110
[patent_app_country] => US
[patent_app_date] => 1991-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 9
[patent_no_of_words] => 5201
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/147/05147641.pdf
[firstpage_image] =>[orig_patent_app_number] => 719110
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/719110 | Microcapsule for the removal of specific amino acids through the entero-portal recirculation | Jun 23, 1991 | Issued |
Array
(
[id] => 2900619
[patent_doc_number] => 05217998
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-06-08
[patent_title] => 'Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid'
[patent_app_type] => 1
[patent_app_number] => 7/715881
[patent_app_country] => US
[patent_app_date] => 1991-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 10647
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/217/05217998.pdf
[firstpage_image] =>[orig_patent_app_number] => 715881
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/715881 | Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid | Jun 16, 1991 | Issued |